Crossmark

Comparative outcomes of thrombocytopenic acute leukemic patients with venous thromboembolism at a Comprehensive Cancer Center

Crossref DOI link: https://doi.org/10.1007/s11239-018-1621-6

Published Online: 2018-02-07

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khan, Maliha

Cox, Travis M.

Nassif, Mohammed

Alzubaidi, Mohanad A.

Garg, Naveen

Qiao, Wei

Aung, Fleur M.

Oo, Thein Hlaing https://orcid.org/0000-0002-5201-731X
Rojas-Hernandez, Cristhiam M. https://orcid.org/0000-0003-3890-3929
License Information

Text and Data Mining valid from 2018-02-07
More Information

Article History

First Online: 7 February 2018

Compliance with ethical standards

:

: CMR and THO have received funding from Daichii Sankyo for clinical research not related to the current manuscript. NG is the CEO of Garglet LLC, a radiology informatics software company. MK, TC, MN, MA, WQ and FA have nothing to disclose.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local IRB.

: The study was approved by the local IRB with waiver of consent. The research involved no more than minimal risk to the subjects. The waiver did not adversely affect the rights and welfare of the subjects, and the research cannot practicably be carried out without the waiver.